The PSAT1 gene helps cells make serine, a building block your body needs for brain development, nerve function, and many everyday cell tasks. If this gene does not work properly, serine levels can drop and a person may develop a rare condition with seizures, slow growth, a small head size, and developmental delays. Most people never hear about the PSAT1 gene outside genetic testing or specialist care. In medicine, this gene is important because it helps regulate one of the body’s basic pathways for growth and brain health.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage processes in the body. Some genes carry the directions for building proteins, which are the working parts of cells. Other genes are mainly involved in controlling when certain processes happen, where they happen, and how strongly they run. As a whole, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
PSAT1Gene function
What if the gene works
The PSAT1 gene helps your cells make serine, an amino acid used to build proteins and support normal cell growth and brain function.
Risk
What if the gene does not work
Variants in the PSAT1 gene can reduce serine production, which is important for brain development. Milder to more severe variants may cause developmental delay and seizures, or in some cases severe problems with growth and brain development before birth.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the PSAT1 gene can make L-serine supplementation, often paired with glycine, the main treatment approach. This replacement therapy helps raise serine levels and may improve seizures and development, especially when started early. No separate PSAT1-specific drug choice beyond this metabolic treatment is established.
Conditions associated with PSAT1
Gene function
What if the gene works
Your cells use the PSAT1 gene during routine metabolism to make serine, an amino acid needed every day. This steady supply supports normal cell upkeep and growth. When the gene is working properly, this middle step in serine production connects smoothly with the steps before and after it.
The PSAT1 gene carries out a central step in the pathway that makes serine. Its protein turns one small starter molecule into the next form your cells need to keep serine production moving.
The protein from the PSAT1 gene transfers an amino group, a small nitrogen-containing part, between molecules. This is how the PSAT1 gene helps cells make serine as part of normal amino acid metabolism.
By supporting serine production, the PSAT1 gene helps cells maintain materials used for proteins and other basic cell components. This supports everyday growth, renewal, and routine cell maintenance.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not lead to any noticeable effects and simply represent natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In understanding how PSAT1 gene variants affect enzyme activity, the main change is usually a drop in how well the protein works or how stable it is inside cells. Some variants leave partial activity, while more severe variants can sharply reduce or nearly eliminate function, including shortened proteins that break down early. This can lead to a wider or deeper shortage of serine, and in PSAT1-related conditions it may influence how early features appear and how pronounced they are.
How variants are linked to conditions
The main PSAT1 gene variants linked to conditions are pathogenic changes in both copies of the gene, which cause phosphoserine aminotransferase deficiency, a rare inherited condition associated with small head size, developmental delay, seizures, and growth problems. More severe variants in the PSAT1 gene can lead to Neu-Laxova syndrome 2, which affects growth and brain development before birth.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant connected with a condition indicates a possible link rather than a certain diagnosis, particularly when several genes and environmental influences play a part. In some situations, though, one well understood variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For PSAT1, risk is mainly shaped by inheritance rather than lifestyle. A child’s chance of having a PSAT1-related condition is higher when both biological parents carry a harmful change in the PSAT1 gene or there is a family history of the condition. There is not enough evidence to say that diet, exercise, or other everyday factors lower this gene-related risk.
Inheritance of PSAT1 variants
Variants in the PSAT1 gene linked to known PSAT1-related conditions are inherited in an autosomal recessive pattern. This means a person usually inherits one altered copy from each parent, and the parents are often healthy carriers. When both parents carry a PSAT1 variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. In practical terms, the PSAT1 inheritance pattern means it can affect children of any sex equally.
What does my PSAT1 result mean for my family?
PSAT1-related conditions are usually passed down in a recessive pattern, which means close relatives may be healthy carriers without knowing it. Brothers and sisters could also have the condition or be carriers, and other family members may carry the same gene change. For many families, this means carrier testing may be relevant for relatives, especially when planning a pregnancy.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant, PSAT1 genetic testing analyzes DNA from a blood sample, saliva, or a cheek swab. The lab reads the PSAT1 gene and checks for changes that may help explain symptoms, confirm a genetic diagnosis, or clarify whether someone is a carrier.
When should I consider getting a genetic test?
Testing for changes in the PSAT1 gene may be worth discussing if a baby or child has severe early developmental problems, seizures, an unusually small head size, or if similar problems run in the family. It can also help clarify the cause after an affected pregnancy or repeated pregnancy losses linked to serious brain or growth differences.
A genetic result is only one part of your health story
Genetic results can be very informative, but how much they reveal varies based on the condition and the kind of variant involved. Over time, many factors also influence how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result can give a clear answer. For medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Some people break down or move a drug through the body differently, so the same treatment may work better for one person, have less effect in another, or cause more side effects in someone else. This kind of difference is common and is one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medications. It studies the relationship between genes and drugs to better understand why the same treatment can work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This understanding can support more informed, individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the PSAT1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so questions about side effects, treatment response, or other health concerns are best discussed with your doctor.
History
PSAT1 entered medical genetics through research on how the body makes serine, an amino acid that supports brain growth and many everyday cell functions. Initially understood only through its role in a basic chemical pathway, it was later recognized as tied to rare inherited conditions that affect early development. From these first observations, research expanded steadily. Scientists then connected harmful variants in the PSAT1 gene with phosphoserine aminotransferase deficiency and, in some families, with forms of Neu Laxova syndrome. This helped move PSAT1 from a laboratory finding to a gene with clear clinical importance. Over time, descriptions became more precise as genetic testing linked changes in the PSAT1 gene to a wider range of severity in affected people.